Pharmacodynamic comparison of pantoprazole enantiomers: inhibition of acid-related lesions and acid secretion in rats and guinea-pigs

Authors: Cao, Hong1; Wang, Min-Wei1; Sun, Li-Xin1; Ikejima, Takashi2; Hu, Zhi-Qing3; Zhao, Wei-Hua4

Source: Journal of Pharmacy and Pharmacology, Volume 57, Number 7, July 2005 , pp. 923-927(5)

Publisher: Pharmaceutical Press

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Pantoprazole is an irreversible proton pump inhibitor that is administered as a racemic mixture clinically. The effects of pantoprazole sodium (PAN·Na) enantiomers on acid-related lesions were compared using models of pylorus ligation induced ulcer, histamine induced ulcer and reflux oesophagitis in rats and guinea-pigs. Compared with (+)-PAN·Na and (±)-PAN·Na, (-)-PAN·Na showed much stronger inhibitory effects on pylorus ligation induced and histamine induced ulcers, but similar effects on reflux oesophagitis. The doses of (-)-PAN·Na, (+)-PAN·Na and (±)-PAN·Na required for 50% inhibition (ID50) of acid-related lesions were 1.28, 5.03 and 3.40 mg kg-1 against pylorus ligation induced ulcer, 1.20, 4.28 and 3.15 mg kg-1 against histamine induced ulcer, and 2.92, 3.56 and 3.70 mg kg-1 against reflux oesophagitis, respectively. The inhibitory effects of PAN·Na enantiomers on basal gastric acid output were compared in rats with acute fistula. In contrast to inhibitory rates of 89.3% and 83.6% on gastric acid output by (-)-PAN·Na and (±)-PAN·Na at 1.5 mg kg-1, (+)-PAN·Na had an inhibitory rate of only 24.7% at the same dose. The above results indicate that (-)-PAN·Na is more potent than (+)-PAN·Na at inhibiting acid-related lesions owing to its stronger inhibition of acid secretion.

Document Type: Short communication

DOI: 10.1211/0022357056361

Affiliations: 1: Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang, China 2: China-Japan Research Institute of Medical and Pharmaceutical Sciences, Shenyang Pharmaceutical University, Shenyang, China 3: Department of Microbiology and Immunology, Showa University School of Medicine, Tokyo, Japan 4: Department of Medical Biology, Showa University School of Medicine, Tokyo, Japan

Your trusted access to this article has expired.

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$38.34 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A